Journal of Society of Preventive Korean Medicine (대한예방한의학회지)

Society of Preventive Korean Medicine (대한예방한의학회)
권호 표지

The Analysis of usage and characteristic of Cancer-Related Anorexia Symptom Assessment Tool

암 환자 식욕부진 증상 평가 도구의 활용 및 특성에 대한 분석

  • Oh, So-Mi (Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Cheon, Chunhoo (Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Park, Sunju (Department of Preventive Medicine, College of Korean Medicine, Daejeon University) ;
  • Jang, Bo-Hyoung (Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Park, Jeong-Su (Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Jang, Soobin (Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Shin, Yongcheol (Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Ko, Seong-Gyu (Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University)
  • 오소미 (경희대학교 한의과대학 예방의학교실) ;
  • 전천후 (경희대학교 한의과대학 예방의학교실) ;
  • 박선주 (대전대학교 한의과대학 예방의학교실) ;
  • 장보형 (경희대학교 한의과대학 예방의학교실) ;
  • 박정수 (경희대학교 한의과대학 예방의학교실) ;
  • 장수빈 (경희대학교 한의과대학 예방의학교실) ;
  • 신용철 (경희대학교 한의과대학 예방의학교실) ;
  • 고성규 (경희대학교 한의과대학 예방의학교실)
  • Received : 2013.11.22
  • Accepted : 2013.12.18
  • Published : 2013.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : Anorexia is the primary symptom impinging cancer patients' Quality of Life. It is usually accompanied by gastrointestinal symptoms(GI symptoms). Thus, to measure anorexia symptom precisely, assessing anorexia and GI symptoms together is recommended. This study was designed to analyze cancer-related anorexia assessment tools, extract GI symptoms included in these tools and investigate usefulness of instruments in clinical trials. Methods : Instruments were selected by searching PubMed, PROQOLID database. We analyzed instruments by number of items, assessment method, type of question, GI symptoms. Results : 9 instruments were selected to assess cancer-related anorexia symptom. Most tools adopt Likert scale as response scale and 'during past week' as recall period. Assessment method of all 9 instruments is the self-administration. Questions measuring anorexia are able to be sorted into 3 forms (frequency, severeness, distress of anorexia symptom). Among the GI symptoms, nausea is included in all 9 instruments. In clinical trials of cancer-related anorexia, Edmonton Symptom Assessment Scale(ESAS) and Functional Assessment of Anorexia/Cachexia Therapy Questionnaire(FAACT) were selected as endpoint measure. Conclusions : The result showed that FAACT is the only specialized tool to assess cancer-related anorexia. To measure cancer-related anorexia precisely, the need to develop new instrument exists.

Keywords

References

  1. 통계청, 2012 사망원인통계.
  2. 국가암정보센터. available:http://www.cancer. go.kr
  3. Kim SG, Hahm MI, Choi KS, Seung NY, Shin HR, Park EC. The economic burden of cancer in Korea in 2002. Eur J Cancer Care. 2008; 17(2):136-44. https://doi.org/10.1111/j.1365-2354.2007.00818.x
  4. Jimenez A, Madero R, Alonso A, Martinez-Marin V, Vilches Y, Martinez B, Feliu M, Diaz L, Espinosa E, Feliu J. Symptom clusters in advanced cancer. J Pain Symptom Manage. 2011;42(1):24-31. https://doi.org/10.1016/j.jpainsymman.2010.10.266
  5. Trajkovic-Vidakovic M, de Graeff A, Voest EE, Teunissen SC. Symptoms tell it all: a systematic review of the value of symptom assessment to predict survival in advanced cancer patients. Crit Rev Oncol Hematol. 2012;84(1):130-148. https://doi.org/10.1016/j.critrevonc.2012.02.011
  6. Lis CG, Gupta D, Grutsch JF. Can anorexia predict patient satisfaction with quality of life in advanced cancer? Support Care Cancer. 2009;17(2):129-135. https://doi.org/10.1007/s00520-008-0447-8
  7. Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K. Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J pain Symptom Manage. 2003;25(5):420-9. https://doi.org/10.1016/S0885-3924(03)00074-5
  8. Ohno T, Yanai M, Ando H, Toyomasu Y, Ogawa A, Morita H, Ogata K, Mochiki E, Asao T, Kuwano H. Rikkunshito, a traditional Japanese medicine, suppresses cisplatin-induced anorexia in humans. Clin Exp Gastroenterol. 2011;(4):291-6. https://doi.org/10.2147/CEG.S26297
  9. Lee JJ, Lee JJ. A phase II study of an herbal decoction that includes Astragali radix for cancer-associated anorexia in patients with advanced cancer. Integr Cancer Ther. 2010;9(1):24-31.
  10. Li J, Li L, Liu R, Lin HS. Establishing Chinese medicine characteristic tumor response evaluation system is the key to promote internationalization of Chinese medicine oncology. Chin J Integr Med. 2012; 18(10):730-736. https://doi.org/10.1007/s11655-012-1254-0
  11. Yavuzsen T, Walsh D, Davis MP, Kirkova J, Jin T, LeGrand S, Lagman R, Bicanovsky L, Estfan B, Cheema B, Haddad A. Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia. Support Care Cancer. 2009;17(12):1531-1541. https://doi.org/10.1007/s00520-009-0623-5
  12. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;30A(9):1326-1336 https://doi.org/10.1016/0959-8049(94)90182-1
  13. Chang VT, Hwang SS, Kasimis B, Thaler HT. Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale(CMSAS). CancerInvest. 2004;22(4):526-36.
  14. Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT. The memorial symptom assessment scale short form (MSAS-SF). Cancer. 2000;89(5):1162-71. https://doi.org/10.1002/1097-0142(20000901)89:5<1162::AID-CNCR26>3.0.CO;2-Y
  15. Cleeland CS, Mendoza TR, Wang XS, Chou C, Harl MT, Morrissey M, Engstrom MC. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000;89(7):1634-46. https://doi.org/10.1002/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V
  16. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):6-9.
  17. Claessens P, Menten J, Schotsmans P, Broeckaert B. Development and validation of a modified version of the Edmonton Symptom Assessment Scale in a Flemish palliative care population. Am J Hosp PalliatCare. 2011;28(7):475-82. https://doi.org/10.1177/1049909111400724
  18. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3): 570-9.
  19. Ribaudo JM, Cella D, Hahn EA, Lloyd SR, Tchekmedyian NS, Von Roenn J, Leslie WT. Revalidation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire. Qual Life Res. 2000;9(10):1137-46. https://doi.org/10.1023/A:1016670403148
  20. Aaronson NK, Bullinger M, Ahmedzai S. A modular approach to quality-of-life assessment in cancer clinical trials. Recent Results Cancer Res. 1988;111:231-49. https://doi.org/10.1007/978-3-642-83419-6_27
  21. Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S. Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol. 1995;13(5):1249-54.
  22. De Haes JCJM, van Knippenberg FCE, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer. 1990;62:1034-8. https://doi.org/10.1038/bjc.1990.434
  23. Hopwood P, Howell A, Maguire P. Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer. 1991;64(2):353-6. https://doi.org/10.1038/bjc.1991.305
  24. McCorkle R, Young K. Development of a symptom distress scale. Cancer Nurs. 1978 Oct;1(5):373-8.
  25. Apfelbaum JL, Gan TJ, Zhao S, Hanna DB, Chen C. Reliability and validity of the perioperative opioid- related symptom distress scale. Anesth Analg. 2004;99(3):699-709. https://doi.org/10.1213/01.ANE.0000133143.60584.38
  26. Yun YH, Mendoza TR, Kang IO, You CH, Roh JW, Lee CG, Lee WS, Lee KS, Bang SM, Park SM, Cleeland CS, Wang XS. Validation study of the Korean version of the M.D. Anderson Symptom Inventory. J Pain Symptom Manage. 2006 Apr;31(4): 345-52. https://doi.org/10.1016/j.jpainsymman.2005.07.013
  27. Kwon JH, Nam SH, Koh S, Hong YS, Lee KH, Shin SW, Hui D, Park KW, Yoon SY, Won JY, Chisholm G, Bruera E. Validation of the edmonton symptom assessment system in korean patients with cancer. J Pain Symptom Manage. 2013;46(6):947-56. https://doi.org/10.1016/j.jpainsymman.2013.01.012
  28. Yun YH, Park YS, Lee ES, Bang SM, Heo DS, Park SY, You CH, West K. Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res. 2004 May;13(4): 863-8. https://doi.org/10.1023/B:QURE.0000021692.81214.70
  29. Laviano A, Meguid MM, Rossi-Fanelli F. Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies. Lancet Oncol. 2003;4(11):686-94. https://doi.org/10.1016/S1470-2045(03)01247-6
  30. Ribaudo JM, Cella D, Hahn EA, Lloyd SR, Tchekmedyian NS, VonRoenn J, Leslie WT. Re-validation and shortening of the Functional Assessment of Anorexia/ Cachexia Therapy (FAACT) questionnaire. Qual Life Res. 2000;9(10):1137-1146. https://doi.org/10.1023/A:1016670403148
  31. Watanabe SM, Nekolaichuk C, Beaumont C, Johnson L, Myers J, Strasser F. A multicenter study comparing two numerical versions of the Edmonton Symptom Assessment System in palliative care patients. J Pain Symptom Manage. 2011;41(2):456-468. https://doi.org/10.1016/j.jpainsymman.2010.04.020
  32. Yavuzsen T, Davis MP, Walsh D, LeGrand S, Lagman R. Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol. 2005;23(33): 8500-8511. https://doi.org/10.1200/JCO.2005.01.8010
  33. Lagman RL, Davis MP, LeGrand SB, Walsh D. Common symptoms in advanced cancer. Surg Clin North Am. 2005;85(2):237-255. https://doi.org/10.1016/j.suc.2004.11.004